E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

Moody's rates Wyeth notes Baa1

Moody's Investors Service said it affirmed Wyeth's Baa1/Prime-2 ratings and assigned a Baa1 rating to Wyeth's new $1.5 billion senior note offering.

Ratings affirmed include Aa1 senior unsecured notes, debentures, bank credit facility, industrial revenue bonds and pollution control bonds, prospective Baa1 senior unsecured shelf rating, Prime-2 commercial paper and VMIG-2 pollution control bonds.

Ratings assigned include Baa1 senior unsecured notes of $500 million due 2036 and Baa1 senior unsecured notes of $1 billion due 2016. The outlook remains developing.

Wyeth's Baa1 rating continues to reflect its good scale and market position, relatively low product concentration risk and good growth rates in core products including Effexor and Prevnar, Moody's said.

Moody's said Wyeth's key credit risk continues to be the uncertain magnitude of remaining diet drug costs. Wyeth faces a very large number of matrix level claims through the National Settlement Trust, as well a very large number of intermediate and back-end opt out claims.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.